Ladan Eshkevari, CEO of Avesta Ketamine and Wellness, will be presenting at the Annual 2025 Conference of American Society of Ketamine Physicians, Psychotherapists, and Practitioners. The event will take place from January 23 – 25, 2025 in Austin, Texas.
Dr. Eshkevari’s session, “Efficacy of addition of IV Glutathione to standard Ketamine IV therapy in Major Depressive Disorder,” is scheduled for January 25, 2025.
In this session, Dr. Eshkevari will examine work from her recent research paper, conducted at Avesta Ketamine and Wellness with funding for the project provided by the AANA Foundation, and published in the Psychiatry Research.
For more information and to register for the event, please visit the 2025 ASKP3 Annual Conference website here.
